Search Results - "Vollmer, T L"

Refine Results
  1. 1

    Prevalence and treatment of spasticity reported by multiple sclerosis patients by Rizzo, M A, Hadjimichael, O C, Preiningerova, J, Vollmer, T L

    Published in Multiple sclerosis (01-10-2004)
    “…The objective of this study was to characterize the population of multiple sclerosis (MS) patients suffering from spasticity and to evaluate treatment…”
    Get full text
    Journal Article
  2. 2

    Randomized multicenter trial of natalizumab in acute MS relapses: Clinical and MRI effects by O'CONNOR, P. W, GOODMAN, A, WILLMER-HULME, A. J, LIBONATI, M. A, METZ, L, MURRAY, R. S, SHEREMATA, W. A, VOLLMER, T. L, STONE, L. A

    Published in Neurology (08-06-2004)
    “…Relapses in multiple sclerosis (MS) can cause significant neurologic disability. Natalizumab (Antegren) is a humanized anti-alpha4-integrin antibody that…”
    Get full text
    Journal Article
  3. 3

    The dynamic link between the integrity of the immune system and zinc status by Fraker, P J, King, L E, Laakko, T, Vollmer, T L

    Published in The Journal of nutrition (01-05-2000)
    “…The results of more than three decades of work indicate that zinc deficiency rapidly diminishes antibody- and cell-mediated responses in both humans and…”
    Get more information
    Journal Article
  4. 4

    CD4+ CD25+ regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis by Jee, Y, Piao, W.H, Liu, R, Bai, X.F, Rhodes, S, Rodebaugh, R, Campagnolo, D.I, Shi, F.D, Vollmer, T.L

    Published in Clinical immunology (Orlando, Fla.) (01-10-2007)
    “…Abstract CD4+ CD25+ regulatory T cells (Tregs) are potent immunosuppressors that are pivotal in the maintenance of self-tolerance. The involvement of Tregs in…”
    Get full text
    Journal Article
  5. 5

    Proposed diagnostic criteria and nosology of acute transverse myelitis

    Published in Neurology (27-08-2002)
    “…Acute transverse myelitis (ATM) is a focal inflammatory disorder of the spinal cord, resulting in motor, sensory, and autonomic dysfunction. A set of uniform…”
    Get full text
    Journal Article
  6. 6

    A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis by Vollmer, T. L., Sorensen, P. S., Selmaj, K., Zipp, F., Havrdova, E., Cohen, J. A., Sasson, N., Gilgun-Sherki, Y., Arnold, D. L.

    Published in Journal of neurology (01-04-2014)
    “…The phase III placebo-controlled BRAVO study assessed laquinimod effects in patients with relapsing-remitting MS (RRMS), and descriptively compared laquinimod…”
    Get full text
    Journal Article
  7. 7

    A safety and pharmacokinetic study of intravenous natalizumab in patients with MS by SHEREMATA, W. A, VOLLMER, T. L, STONE, L. A, WILLMER-HULME, A. J, KOLLER, M

    Published in Neurology (23-03-1999)
    “…A phase 1, randomized, placebo-controlled, five-level dose escalation safety and tolerability and pharmacokinetic study of a single IV dose of natalizumab was…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Transplantation of Cryopreserved Adult Human Schwann Cells Enhances Axonal Conduction in Demyelinated Spinal Cord by Kohama, Ikuhide, Lankford, Karen L, Preiningerova, Jana, White, Fletcher A, Vollmer, Timothy L, Kocsis, Jeffery D

    Published in The Journal of neuroscience (01-02-2001)
    “…Schwann cells derived from human sural nerve may provide a valuable source of tissue for a cell-based therapy in multiple sclerosis. However, it is essential…”
    Get full text
    Journal Article
  9. 9

    An open-label safety and drug interaction study of natalizumab (Antegren™) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis by Vollmer, T L, Phillips, J T, Goodman, A D, Agius, M A, Libonati, M A, Giacchino, J L, Grundy, J S

    Published in Multiple sclerosis (01-10-2004)
    “…In this open-label drug-interaction trial, we studied 38 patients with relapsing-remitting multiple sclerosis (MS) who received 3.0 or 6.0 mg/kg of natalizumab…”
    Get full text
    Journal Article
  10. 10

    APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis by Shi, J, Zhao, C B, Vollmer, T L, Tyry, T M, Kuniyoshi, S M

    Published in Neurology (15-01-2008)
    “…The role of apolipoprotein E (APOE) polymorphism has been well recognized in other cognitive neurodegenerative disorders, such as Alzheimer disease. Its role…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Neuromuscular responses of patients with multiple sclerosis by Rice, C L, Vollmer, T L, Bigland-Ritchie, B

    Published in Muscle & nerve (01-10-1992)
    “…Muscle weakness, studied in 4 patients with multiple sclerosis (MS), was compared with values from normal subjects. Twitch occlusion showed that normal…”
    Get more information
    Journal Article
  13. 13

    Glatiramer Acetate‐Specific Antibody Titres in Patients with Relapsing / Remitting Multiple Sclerosis and in Experimental Autoimmune Encephalomyelitis by Bomprezzi, R., Schaefer, R., Reese, V., Misra, A., Vollmer, T. L., Kala, M.

    Published in Scandinavian journal of immunology (01-09-2011)
    “…Glatiramer acetate (GA) is an immunomodulatory drug approved for the treatment of clinically isolated syndrome (CIS) and relapsing/remitting multiple sclerosis…”
    Get full text
    Journal Article
  14. 14

    IL-21 Modulates CD4⁺ CD25⁺ Regulatory T-Cell Homeostasis in Experimental Autoimmune Encephalomyelitis by Piao, W.-H, Jee, Y.H, Liu, R.L, Coons, S.W, Kala, M, Collins, M, Young, D.A, Campagnolo, D.I, Vollmer, T.L, Bai, X.-F, La Cava, A, Shi, F.-D

    “…The homeostasis of CD4 ⁺ CD25 ⁺ regulatory T cells (Tregs) depends on the cytokine interleukin (IL)-2. As IL-21 shares sequence homology with IL-2 and the…”
    Get full text
    Journal Article
  15. 15

    Ocular myasthenia: a protean disorder by Weinberg, D A, Lesser, R L, Vollmer, T L

    Published in Survey of ophthalmology (01-11-1994)
    “…Ocular myasthenia is a localized form of myasthenia clinically involving only the extraocular, levator palpebrae superioris, and/or orbicularis oculi muscles…”
    Get more information
    Journal Article
  16. 16

    A new EAE model of brain demyelination induced by intracerebroventricular pertussis toxin by Zhao, C.B., Coons, S.W., Cui, M., Shi, F.D., Vollmer, T.L., Ma, C.Y., Kuniyoshi, S.M., Shi, J.

    “…Experimental autoimmune encephalomyelitis (EAE) is a primary animal model of multiple sclerosis (MS). MS predominantly presents with evidence of lesions in the…”
    Get full text
    Journal Article
  17. 17

    Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS by Vollmer, TL, Waldor, MK, Steinman, L, Conley, FK

    Published in The Journal of immunology (1950) (01-06-1987)
    “…Central nervous system toxoplasmosis causes disability and death in up to 30% of patients with acquired immune deficiency syndrome (AIDS). The source of the…”
    Get full text
    Journal Article
  18. 18

    Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen by Vollmer, Timothy L, Liu, Ruolan, Price, Mary, Rhodes, Susan, La Cava, Antonio, Shi, Fu-Dong

    Published in The Journal of immunology (1950) (01-03-2005)
    “…The cytokine IL-21 is closely related to IL-2 and IL-15, a cytokine family that uses the common gamma-chain for signaling. IL-21 is expressed by activated…”
    Get full text
    Journal Article
  19. 19

    Lhermitte's sign in a patient with herpes zoster by Vollmer, T L, Brass, L M, Waxman, S G

    Published in Journal of the neurological sciences (01-12-1991)
    “…A 34-year-old, previously healthy man developed herpes zoster (shingles) involving the C4 dermatome. This was accompanied by Lhermitte's sign, i.e. an electric…”
    Get more information
    Journal Article
  20. 20